SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004988
Filing Date
2021-04-28
Accepted
2021-04-28 08:00:22
Documents
6
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210617xdef14a.htm DEF 14A 834537
2 GRAPHIC tmb-20210617xdef14a014.jpg GRAPHIC 80228
3 GRAPHIC tmb-20210617xdef14a015.jpg GRAPHIC 77388
4 GRAPHIC tmb-20210617xdef14a001.jpg GRAPHIC 5894
5 GRAPHIC tmb-20210617xdef14a002.jpg GRAPHIC 4312
6 GRAPHIC tmb-20210617xdef14a003.jpg GRAPHIC 6748
  Complete submission text file 0001558370-21-004988.txt   1076697
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 21861388
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences